The global somatostatin receptor type market is anticipated to grow at a considerable CAGR during the forecast years. The major factor for the growth in the global somatostatin receptor type market is the new developments in the somatostatin receptor type for better treatment. For instance, in November 2021, Crentics Pharmaceuticals, Inc. announced new data for the poster presentation at the annual Society for Endocrinology BES congress. The data is collected from the ongoing open-label extension (OLE) trials. The trials are based on the effects of paltusotine in acromegaly patients. Paltusotine is a nonpeptide agonist that is highly selective for the investigation with somatostatin receptor type 2.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/somatostatin-receptor-type-market
In addition, according to a report by The Journal of Clinical Endocrinology and Metabolism (JCEM) published in October 2021, first-generation somatostatin receptor ligands are the major treatment for patients with acromegaly. Furthermore, the increasing number of patients suffering from hormonal disorders are increasing due to several reasons including pituitary tumors, stress, injury, medications, during cancer treatments, and many other. Thus, increasing the use of somatostatin receptor type for the treatment or management of hormonal disorders. Thus, several research and developments activities and increasing patients with hormonal disorders are expected to propel the growth of the global somatostatin receptor type market.
Market Coverage
- The market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
o By Type
o By Application
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape- Chiasma, Inc., GlaxoSmithKline plc, Merck Group, Novartis International AG, Peptide Logic LLC, and Others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Somatostatin Receptor Type Market Report Segment
By Type
- SSTR 1
- SSTR 2A
- SSTR 2B
- SSTR 3
- SSTR 4
- SSTR 5
By Application
- Hormonal Disorder
- Cancer
- Alzheimer’s Disease
A full report of Somatostatin Receptor Type Market is available at: https://www.omrglobal.com/industry-reports/somatostatin-receptor-type-market
Somatostatin Receptor Type Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Pfizer Inc.
- Bristol Myers Squibb (BMS)
- Strongbridge Biopharma
- Amryt Pharma plc
- Daewoong Pharmaceuticals Co. Ltd.
- Ipsen
- Lantheus Medical Imaging
- Zucara Therapeutics
- AstraZeneca group Co.
- Eli Lilly and Co.
- Hoffmann-La Roche Ltd.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
